chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left posterior arm: Red, warm to touch, feels hard, mild pain 3/10 w/ pressure. No fevers. After Vaccine was administered patient stated she went outdoor horse riding, felt fatigue, and very tired after.
Crying non stop for 4 hours.  Temperature 102, not responding to Tylenol.  Advised luke warm baths, supportive care.
Improper preparation of thawed vial; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Improper preparation of thawed vial) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical history was provided by the reporter.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Improper preparation of thawed vial). On 21-Apr-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Improper preparation of thawed vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Thawed vial was stand in a room temperature, however they put the vial in front of a sitting fan for 30 minutes then administered to patient. Action taken with mRNA-1273 in response to the events was not Applicable. Concomitant and treatment information not provided
I received my Pfizer booster in August 2021. On 1/6/2022, I took a PCR test at (Privacy). The result was positive. Even though I had a breakthrough case, I'm still glad I was fully vaccinated, because I just had a fever and a sore throat for three days.
Vomiting, right deltoid is red, swollen, hard and hot to the touch. Symptoms began about 4:30 am on 6/21/17.
Site: Pain at Injection Site-Mild, Systemic: Chills-Mild, Additional Details: patient felt chills, pharmacist follow up on sunday patient feeling better a little sore on the arm but nothing else
This spontaneous report as received from a nurse refers to a 6 month old patient of an unknown gender. On 05-FEB-2015, the patient was vaccinated with improperly stored ROTATEQ (lot # K007247 and expiry date: 17-MAR-2016 or lot# K006805 and expiry date: 24-MAR-2016). No adverse events were reported. No product quality complaint (PQC) was reported for ROTATEQ. This is one of the several reports from the same reporter. Additional information has been requested.
9/3/12 - Chills 4.20am - 4.50am. 9/3/12 - Chills 5.30pm - 5.45pm. 12/3/12 - Chills 9.00pm - 9.30pm. 12/5/12 - Chills 6.00am - 6.30am.
Swelling, no pain, down to elbow. Redness too. Went to ER for treatment. Given KEFLEX. Showing improvement by 10/16/11.
This spontaneous report as received from a healthcare worker (medical assistant) refers to a patient of unknown demographics. No concurrent conditions or medical history were provided. On 27-MAR-2015, the patient was vaccinated with a dose of improperly stored GARDASIL injection (lot # J011272 with expiry date: 21-APR-2016, reported as: 20-APR-2016; strength, dose and route of administration unspecified). It was confirmed the vaccine was not GARDASIL 9. No concomitant medications were reported. No adverse effects were noted. Additional information has been requested.
Patient came to the office today complaining of right upper arm itching/red after getting Pneumovax yesterday at office appt.  It started last PM and continue to get worse today. He used OTC itching cream with no help. Denies any resp distress.  Right upper arm red/swollen and warm to touch. He has a fine red rash over trunk of body but denies itching there.  Addressed with NP since couldn't get in contact with Dr. NP vorv Depo Medrol 80 mg IM now with a f/u appt and OTC Benadryl. Dr called into the office and notified of situation and NP orders. He agreed and vorv Xyzal one bid OTC for itching since Benadryl can be sedative. Injection given and instructed patient of OTC medications and appt date/time for Friday with NP.He verbalized understanding. Called staff  at Health Dept and had to leave a message to call the office on reaction.
Right arm very sore on 11/19/21. Next day chills and all over muscle aches beginning at approximately 2Pm . Chills subsided approximately 10pm. Temperature at 99.2. Today, no chills but feeling groggy and no appetite.
Client received Janssen vaccine on 3/27/2021.  Symptom onset 6/29/2021 with a cough and sore throat.  Tested positive for Covid-19 on 7/7/2021.
Within 12 hours was having trouble breathing heart pounding thought I could just rest and could not it was so bad  went to the ER on 2/14/21 @ 8:30 am my O2 was at 87 dropped to 81 BP was 158/101
pt recvd vax;apap given;became feverish,fussy,T 104.5;sore leg,red,swollen below knee;advil also given;cried off & on;fell asleep;next am seemed ok;would cry & calm down & get up screaming again,this went on all noc;
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 04-JAN-2016 the patient was vaccinated with an improperly stored dose of GARDASIL (lot # K016966, expiration date 10-MAY-2017, dose and route not reported). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion five times. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) for each time were 112, 30 and R; 24, 31 and R; 24, 32 and R; 104, 33 and R; 72, 29 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
2nd Hep A was administered before due date. Patient was notified before leaving by medical assistant and provider. Provider assured no harm done, no extraordinary reaction anticipated - Hep A will be given again at proper time. VIS  given to parent. Nothing unusual noted about patient condition before leaving appt.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. On an unkonwn date, the patients were vaccinated with doses of PROQUAD (Merck) (Lot # L005295 exp date 17-AUG-2016) (dose and route not reported). No adverse effects were reported. Additional information is not expected as the reporter did not wish further contact.
Pain in/under arm pit; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202200092479 (Pfizer).  A 55 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 15Jan2022 (Batch/Lot number: unknown) at the age of 55 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Blood pressure high" (ongoing). Concomitant medication(s) included: HYDROCHLOROTHIAZIDE taken for hypertension (ongoing); AMLODIPINE BESYLATE taken for hypertension (ongoing). Vaccination history included: Bnt162b2 (Dose number: 1, Lot number: unknown, Expiration date: unknown, NDC: unknown), administration date: Mar2020, for Covid-19 immunisation; Bnt162b2 (Dose number: 2, Lot number: unknown, Expiration date: unknown, NDC: unknown), administration date: Mar2020, for Covid-19 immunisation. The following information was reported: AXILLARY PAIN (non-serious) with onset 16Jan2022, outcome "not recovered", described as "Pain in/under arm pit".  Additional information: Patient got the Pfizer Booster, clarified to be the Pfizer Covid Booster and she was having pain in her arm pit .She wanted to know if this was normal an reported it as a side effect to the vaccine. Patient had pain in arm pit/under arm pit. Confirmed this was on the left side. Time the vaccination was given was around noon. It was around bedtime, around 9:00 or 10:00 PM. Vaccination Facility Type was Hospital. Caller confirmed her previous doses were the Pfizer Covid Vaccine and had no details to provide. It was sometime in Mar2020. There were no additional vaccines administered on same date of the Pfizer suspect. There were no prior vaccinations (within 4 weeks) and no adverse events following prior vaccinations. Relevant tests were reported as none.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Moderna COVID-19 Vaccine  Felt jittery but mis-attributed to maybe lowish, 85, blood sugar or nerves. This continued after eating a d blood sugar was higher but did subside in evening. 20 minutes after vaccine mild tingling in lip and then left side of face, approx 1 hr later mild swelling below lip. Called Triage nurse, went to ER as a precaution but it did not progress. Took Benadryl after visit and next day. Will add a second allergy med per Drs advice.
Patient and parent presented to the Urgent Care to receive COVID vaccine. Parent told registration staff that patient was 12 years old, so staff registered pt for vaccine. Pt age was not verified one entered into the system and was not caught by clinical staff. Pt received 1st adult dosage 2 months before they turned 12 years on 8/21/2021 and second dosage  on 9/17/2021. No adverse reaction to the vaccine noted.
A few weeks later, I broke out in hives. The doctor believes my body was overproducing histamine in response to a cold or possibly weakened immune system from the vaccine. I have broken out in hives after a vaccine before but it was never this delayed.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 28-AUG-2014, the patient was inoculated with the ZOSTAVAX vaccine at a pharmacy as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. On or about 20-JUN-2015, the patient was treated by a nurse practitioner for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster. The patient was prescribed acetaminophen and FAMVIR for management of her painful symptoms and excruciating pain. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Spoke with pt's mother. Pt's mother reported that pt complained of severe pain on 8/16/21 after vaccination in PM. Pt reported to MOP-she noted a lump in armpit near breast in arm where vaccine was administered. Mother of patient could not identify arm where lump was or describe what the lump looked like. Mother of patient reported that pt continued to complain of pain (unk severity). Mother of patient reported patient did not want to go to MD today due to today being first day of school. Encouraged mother of patient to contact patient's PCP and follow-up with provider to be assessed. Mother of patient verbalized understanding.
Fever; chills; malaise; vomiting; This is a spontaneous report from a contactable consumer (patient) via company representative. A 43-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on 12Apr2021 at the age of 43 years old (Batch/Lot number was not reported) as 2nd dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 for covid-19 immunisation. It was reported that after Second dose of BNT162b2 vaccine (week of 12Apr2021), patient experienced fever, chills, malaise and vomiting on 12Apr2021 for 24 hours and symptoms resolved. Events took place after use of product. The outcome of the events was recovered in Apr2021.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Information has been received from a physician concerning 4 patients who were vaccinated with Rotateq. The physician reported that each of the 4 patients received the first dose of Rotateq after 12 weeks and the third dose after 32 weeks. The physician had no other detailed information on the patients. The patient did not report any symptoms. Attempts to obtain patient identifiers are being made. Additional information has been requested.
Dizziness, and body ache. Went to bed at 7 pm and woke up at midnight sweating then cold and dizzy. Finished out the night sleeping and woke up relatively normal
Info has been received from a dental hygienist concerning her 13 month old son who on approximately 10/16/05, was vaccinated with a dose of varicella virus vaccine live. The dental hygienist reported that in 11/05, her son developed chickenpox. Unspecified medical attention was sought and the pt was referred to an infectious disease physician. At the time of this report, the outcome was unknown. Additional info has been requested.
Swollen raised area about the size of a Nickle and redness at injection site 2 weeks post injection. Dr. consulted on 3/4, told to just observe. Grew larger and more inflamed. Obvious sign of infection and  Dr. consulted again on 3/9. Patient given antibiotic injection that day and prescribed Doxycycline Hyclate 100mg tab - one tablet twice daily for 10 days.   (pictures taken often for comparison)
had a light fever and sore arm after vaccine, started complaining of chest pain the night after vaccine , a few days later started complaining about not being able to breath and face was swollen, mom rushed to hospital and they said his oxygen level was low and he was having a asthma attack which he hasn't had since he was a baby. hospital had to give him 8 treatments of albuterol. my son is still not completely back to his normal self
2-6-09 Client phoned in and report he had a reaction to pneumonia injection given 2-5-09 here @ PCHD.  Instructed client to take BENADRYL OTC and come in to health Dept for nurse to check the arm.  2-6-09 1:15pm Client R increase arm swollen and warm to touch.  R bicep 34.5 cm L bicep 31.0 cm.  Client reports swelling started on deltoid muscle where shot was given.  Then, dropped to bicap.  Advised cold compress and go to ER.
Reported feeling minor SOB and felt like her throat was closing about 30-40 minutes after receiving the vaccines. States that she was driving home when she started having DOB. She took OTC Benadryl PO and the issue resolved.
Chest pressure, diffuse myalgias that developed an hour after getting vaccine, lasted 2 weeks, resolved spontaneously.
Tenderness, warmth and redness at site of immunization. Becoming more red and painful. Began as the size of a quarter and today it's the size of an orange. Hard and painful.
This case was reported by a other health professional via call center representative and described the occurrence of fever in a 16-year-old male patient who received BEXSERO (batch number 16D401, expiry date 28th February 2019) for prophylaxis. Co-suspect products included MENVEO (batch number A17041, expiry date 30th April 2019) for prophylaxis. On 9th May 2018, the patient received the 1st dose of BEXSERO and MENVEO. On 11th May 2018, 2 days after receiving BEXSERO and MENVEO, the patient experienced fever (serious criteria other: as per reporter). On 13th May 2018, the patient experienced swelling of fingers (serious criteria other: as per reporter) and rash (serious criteria other: as per reporter). The patient was treated with prednisone. On an unknown date, the outcome of the fever, swelling of fingers and rash were recovered/resolved. It was unknown if the reporter considered the fever, swelling of fingers and rash to be related to BEXSERO and MENVEO. Additional details were provided as follows: This case was reported by the Medical Assistant (MA). At 16:30 hours, the patient received Bexsero in left deltoid and Menveo in right deltoid. The patient developed fever of 102 degrees. Three days after receiving BEXSERO and MENVEO, the patient developed bilateral hand and finger swelling. The patient went to the emergency room and was started on Prednisone. A few hours later the patient developed a rash on his hands, chest, and arms. The patient went to an allergist after the rash developed.
pt devel a fever & had a sz lasting for several seconds;pt was taken to ER dx w/OM, & treated w/ATB
headache, sore throat, fatigue, winded easily, cough, body aches, diarrhea. starting 12/31/21
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history, concomitant therapies, drug reactions or allergies were not reported. On 13-AUG-2018, the patient was vaccinated with one dose of improperly stored ROTATEQ orally (lot # R002513, expiration date: 05-JUN-2019, dose was not provided) for prophylaxis. No adverse effect reported; one dose of improperly stored ROTATEQ was administered. This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history, concomitant therapies, drug reactions or allergies were not reported. On 13-AUG-2018, the patient was vaccinated with one dose of improperly stored ROTATEQ orally (lot # R002513, expiration date: 05-JUN-2019, dose was not provided) for prophylaxis. Administered dose of vaccine experienced temperature excursion between 2-8 degrees Celsius (1.8 degrees Celsius) for 10 hours. There was previous temperature excursion between 0-1 degrees Celsius for 45 minutes. Digital data logger was involved. No adverse effects were reported. This is one of two cases reported be the same reporter. Sender's Comments: US-009507513-1808USA008009: Administered dose of vaccine experienced temperature excursion between 2-8 degrees Celsius (1.8 degrees Celsius) for 10 hours. There was previous temperature excursion between 0-1 degrees Celsius for 45 minutes. Digital data logger was involved. No adverse effects were reported. This is one of two cases reported be the same reporter. Sender's Comments: US-009507513-1808USA008009.
Delayed localized reaction to immunization, 1-20-10 Lt deltoid redness with inflammation warm to the touch size of a silver dollar. Arm sore since injection 1-18-10 pt will alt ice with hot compresses, take 1 ibuprofen 400mg QID BENADRYL 50x 1st dose then 25-50 q 6hrs, and return to office if arm gets worse. So getting better arm not as red, not as warm to touch and inflammation going down.
Patient seemed to faint / look like they had a seizure, no seizure history, color recovered to face once we  laid her down and lifted legs up. EMS was called and assessed patient.
Day 8:  Red patch on arm and hot (did not have this during previous week) Day 10:  body aches, headache, low grade fever (99.4 and usually 97)
This is a spontaneous report from a contactable reporter via a call center. A mother reported on behalf of her daughter. A female patient (age and race unknown) received a dose of PREVNAR on an unknown date. Relevant medical history, concomitant medications and past product history were unknown. It was reported that the patient developed bronchiolitis within 48 hours after being administered the PREVNAR. Relevant laboratory data was unknown. Therapeutic measures taken in response to the reported event were unknown. The clinical outcome of the reported event was unknown at the time of report. Follow-up information was received by a second call center from the same reporter on the same day, 24Jan2011. This contactable female consumer reported that her daughter began on PREVNAR unknown dose injection for an unknown reason on an unknown date. Relevant medical history was unknown. Relevant concomitant medications were unknown. Other vaccines given to her was unknown. Vaccine given on the same day was unknown. Vaccines taken within the last four weeks were unknown. On an unknown date while on PREVNAR unknown dose she experienced bronchiolitis within 48 hours of administration of injection. Relevant lab data was unknown. At the time of the report it was unknown if the patient was taking PREVNAR. At the time of the report the clinical outcome of the above event was unknown. Follow-up (16MAR 2011): Follow-up attempts completed. No further information expected.
Maculopapular rash started Monday in AM in the area of where vaccine was given.
Within hours of receiving Men B #2, patient began with redness, warmth, swelling, and discomfort to left upper extremity a vaccination site
#1 dose of Moderna given to 17 year old who was eligible due to working in a facility.
Pt received his 2nd Covid vaccine.  After waiting for 15 mins pt stated that he felt very weak. Pt was seen by FNP. She listened to the pt's heart. She asked for his blood pressure and blood sugar to be checked. She also asked for him to wait an additional 15 mins. After wait time was over pt stated that he felt well enough to leave. He still had weakness but stated it wasn't worse.
This spontaneous report was received from a health professional refers to unspecified patients of unknown demographics. On an unknown date the patients received improperly stored M-M-R II (incorrect product storage). No adverse effects were reported. Outcome of the event, incorrect product storage was unknown. Reporting health professional considered product the event to be not related to M-M-R II. This is one of several reports from the same reporter (MARRS # 1504USA004227 and MARRS # 1504USA004065). Additional information has been requested.
Fine papular widespread rash, very pruritic - onset 2 days after HPV & MENACTRA. Fingers & hands peeled 2 months afterwards. (-) fever.
has been sick; she had a fever and the fever lasted for 4 days; This is a spontaneous report received from a contactable consumer or other non hcp. A 24-years-old female patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE,Batch/Lot Number: EN6207; Expiration Date: 31Jul2021),via an unspecified route of administration, administered in Arm Left on 19Mar2021 11:00,at the age of 24 years old,as Dose 1,single for covid-19 immunization.Medical history included hormone level abnormal and blood prolactin increased from an unknown date and unknown if ongoing. Concomitant medication(s) included cabergoline taken for hormone level abnormal,blood prolactin increased from an unspecified start date and ongoing.The patient experienced she had a fever and the fever lasted for 4 days on 21Mar2021,has been sick on an unspecified date.The patient underwent lab tests and procedures which included body temperature:100 fahrenheit on, body temperature: 102 fahrenheit on 21Mar2021.Therapeutic measures were taken as a result of she had a fever and the fever lasted for 4 days.Tylenol NDC 50580-608-02, LOT PHA151, EXP May2021. Dose 500mg acetaminophen, diphenhydramine-HCI 25 mg, on tablet once daily by mouth. she took one a day the past 2 days.The patient body temp was 102F on 21Mar2021,it has come down to 100F now, which she says is not a lot. Confirmed temperature units with caller as Fahrenheit.The adverse events didn't result on emergency room visit or physician visit.The patient had not received any vaccination within 4 weeks.The outcome of the event was recovering. Follow-up (25Mar2021): This is a follow up spontaneous report from a contactable consumer.patient was calling about the COVID 19 Vaccine.Physician details was updated. Follow-up (30Mar2021): This is a follow-up spontaneous report in response to the mail trail sent regarding the confirmation of the reporter (also the patient's) name. This report included that:reporter details was updated.  No follow-up attempts are possible. No further information is expected.
p/vax pt tested pos for streptococcus pneumoniae meningitis & was hosp;